Active Pharmaceutical Ingredient Market Revenues to Reach Around $ 300 Billion by 2030: P&S Intelligence


NEW YORK, June 24, 2021 / PRNewswire / – The global active pharmaceutical ingredients (API) market is expected to expand rapidly in the coming years, primarily due to increasing drug applications, increasing prevalence of chronic and lifestyle-related diseases such as cancer, cardiovascular disease and diabetes, increase in the geriatric population, increasing investments in biosimilars, implementation of government initiatives to promote the use of generic drugs, proliferation of health care spending, expiration of patented biologics and awareness growing public to diseases.

The COVID-19 pandemic severely disrupted the global active pharmaceutical ingredients market in the first six months of 2020, but several established biopharmaceutical and pharmaceutical companies and start-ups have expanded their businesses to develop effective treatments for the virus, this which subsequently caused an increase in the market. .

Get sample copy of this report at @

Globally, North America is expected to hold the largest share of the API market in the coming years, due to increased research and development (R&D) activities in the field of drugs. However, the Asia Pacific (APAC) will experience the fastest growing market in the years to come. This will be explained by the surge in health spending, the presence of a large number of generic drug manufacturers and the expansion of the patient base in the region. In addition, the growing public awareness of diseases associated with lifestyle is fueling the growth of the industry in this region.

Browse Detailed Report with COVID-19 Impact Analysis on Active Pharmaceutical Ingredients Market Research Report: By Type of Manufacturer (Captive, Merchant), Type (Generic APIs, Innovative APIs), Synthesis Type (Biotech, Synthetic), Drug Type (Prescription Drugs, Over-the-Counter Drugs), Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Pain Management, Respiratory Diseases) – Global Industry Analysis and Estimation revenue through 2030 @ -analysis / active-pharmaceutical-ingredient-api-market

Players operating in the API market are increasingly focusing on product launches to increase their profits. For example: –

  • Bajaj Healthcare Limited has launched an antiparasitic drug called Ivejaj, which can be used by healthcare professionals to treat COVID-19 infection, by June 2021. The company developed the formulation of Ivermectin and API with the help of its own in-house R&D team.

Make inquiries about this report at @

Novartis International AG, Pfizer Inc., Merck & Co. Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., AstraZeneca plc., Boehringer Ingelheim International GmbH, Eli Lilly and Company and Mylan NV are some of the major players in the market for API.

Browse other related reports

Generic Drugs Market ReportGlobally, Asia Pacific generated the highest turnover in the generic drug market in 2019, and this trend is expected to continue in the years to come. This is due to the increase in the geriatric population, skyrocketing healthcare spending, the increasing prevalence of chronic diseases and the growing implementation of government initiatives to promote the use of generics in this region.

Immunotherapy Drugs Market ReportFrom all regions, North America held the largest share of the Immunotherapy Drugs market during the historical period and is expected to maintain its position during the forecast period. The reasons are the increasing prevalence of chronic diseases, the increase in health expenditure per capita, the growth of the geriatric population and the presence of major players in the region.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services addressing the market information needs of growing industries around the world. Providing the bedrock of market intelligence, P&S as an enterprising research and consulting company, believes in providing in-depth landscape analyzes on the ever-changing market scenario, to enable companies to make informed decisions. and to base their business strategies with astuteness.

Prajneesh Kumar
P&S Intelligence
Contact: + 1-347-960-6455
E-mail: [email protected]

SOURCE P&S Intelligence


Leave A Reply